熱療癌症治療市場－全球產業規模、佔有率、趨勢、機會及預測（按設備類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

全球熱療癌症治療市場預計將從 2025 年的 2.0125 億美元成長到 2031 年的 2.8419 億美元，複合年成長率為 5.92%。

熱療是治療方法透過提高人體組織溫度來破壞癌細胞並使其更容易接受同步放射線治療和化療的治療方法。全球癌症負擔日益加重，以及臨床上對多模式治療方法以提高難治性癌症患者存活率的需求，是推動這一市場成長的主要因素。近期疾病統計數據也印證了這個巨大需求。例如，美國癌症協會估計，到2025年，美國將新增2,041,910例癌症病例，凸顯了有效輔助治療性介入的迫切需求。

精準熱療系統高成本且技術複雜，是限制市場成長的主要障礙。部署能夠確保均勻加熱並保護健康組織的先進設備需要大量的資金投入和專業人員培訓，這限制了許多醫療機構的普及。此外，不同地區的醫保報銷政策不盡相同，也阻礙了醫療機構採用這項技術，儘管其臨床療效已得到證實，但仍難以廣泛應用並融入標準治療方案。

市場促進因素

全球腫瘤疾病發生率的不斷上升是市場成長的主要驅動力。日益加重的疾病負擔促使輔助性治療廣泛應用。不斷攀升的癌症發生率迫使醫療系統採用諸如熱療等技術來增強標準治療通訊協定的療效。 2024年2月，世界衛生組織（世衛組織）在《全球癌症負擔》報告中指出，2022年全球新增癌症病例約2,000萬例。深部和難治性惡性腫瘤患者數量的成長尤為顯著，這為專業熱療治療創造了巨大的潛在市場。報告也指出，肺癌是全球新增病例最多的癌症，達250萬例，也是深部局部熱療增強放射治療效果的主要應用領域。

同時，公共和私人對癌症治療基礎設施投入的增加，以及對專業治療中心的投資，正顯著加速市場對熱療的接受度。醫院和研究機構正積極升級其治療設施，並引進先進的熱療系統，以改善患者獲得多方面治療的機會。專用設施的快速成長印證了這一趨勢。根據中國領先的腫瘤專科醫院派瑞克醫療發布的《2024年營運更新報告》顯示，該院計劃在年底前擴建，運作20台熱療設備。這種基礎設施建設反映了醫學界共識的轉變，即把熱療融入主流腫瘤治療流程，以最大限度地提高臨床療效。

市場挑戰

精準熱療系統成本高且技術複雜，成為熱療癌症治療市場擴張的主要障礙。實施這些先進的多效療法需要醫療機構對精密設備進行大量投資，以確保均勻加熱並保護正常組織。初始資本支出加上操作複雜系統所需的專業培訓，造成了營運障礙，使得這些療法主要局限於資金雄厚的研究中心，從而限制了其在臨床環境中的廣泛應用。

此外，報銷範圍的不穩定性嚴重削弱了將這項技術納入標準治療方案的財務可行性。當醫療機構無法為資本密集型治療項目獲得穩定的支付時，經濟風險往往會超過臨床效益。這種嚴峻的財務狀況在近期的政策調整中顯而易見：根據美國放射腫瘤學會2024年的公告，最終版的聯邦醫療保險醫師收費標準將把放射腫瘤服務的報銷額降低約2%，延續了過去十年資本密集型療法支付額持續下降的趨勢。資金的減少直接阻礙了醫療機構購買和維護必要的熱療系統，從而抑制了市場成長。

市場趨勢

磁共振引導即時溫度監測系統的引入，滿足了精確熱劑量測定的關鍵需求，正在革新市場。這一趨勢標誌著技術從靜態加熱向動態、影像引導介入技術的轉變，使臨床醫生能夠即時觀察溫度分佈並即時調整能量輸出。隨著業界致力於檢驗這些精準平台，大量投資正在湧入。例如，Sensius在2025年6月的新聞稿中宣布，已獲得1500萬歐元的資金籌措，用於加速其精準熱療平台的國際臨床部署，這表明市場對影像引導解決方案在頭頸部惡性腫瘤治療領域的商業性前景越來越有信心。

同時，市場正經歷著向非侵入性深層組織微波和超音波療法的重大轉型，這種療法消除了組織間導管置入的風險。隨著高強度聚焦超音波（HIFU）技術的日趨成熟，這項轉型正在加速。 HIFU提供了一種非切口治療方案，無需住院，並能有效提高深部腫瘤的敏感性，以便於後續治療。這些非侵入性設備在臨床上的日益普及，體現在其全球使用量的激增。根據聚焦超音波基金會於2024年7月發布的《2024年產業現況報告》，全球病患治療量較上年度成長了44%，凸顯了非侵入性熱療技術的快速普及。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球熱療癌症治療市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依設備類型（微波熱療設備、超音波熱療設備、紅外線熱療設備、短波熱療設備）
  • 透過用途（前列腺癌、乳癌、子宮頸癌、皮膚癌、其他癌症）
  • 按最終使用者（醫院/診所、專科治療中心、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美熱療癌症治療市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲熱療癌症治療市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章 亞太地區熱療癌症治療市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲熱療癌症治療市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲熱療癌症治療市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球熱療癌症治療市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Pyrexar Medical
• MagForce AG
• Hydrosun Medizintechnik GmbH
• Andromedic Srl
• YAMAMOTO VINITA CO., LTD
• OncoTherm Kft.
• Nanoprobes, Inc.
• Chongqing Haifu Medical Technology Co., Ltd.
• Novavida Integrative Medical Center
• InnoMedicus Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Hyperthermia Cancer Treatment Market is projected to expand from USD 201.25 Million in 2025 to USD 284.19 Million by 2031, registering a CAGR of 5.92%. Hyperthermia therapy involves raising the temperature of body tissues to destroy malignant cells and increase their sensitivity to accompanying radiation or chemotherapy protocols. The market is largely sustained by the growing global burden of cancer and the clinical necessity for multimodal treatments that enhance patient survival in refractory cases. This essential demand is underscored by recent disease statistics; for instance, the American Cancer Society estimates that 2,041,910 new cancer cases will be diagnosed in the United States in 2025, highlighting the critical need for effective adjunctive therapeutic interventions.

A significant barrier to market growth is the high cost and technical complexity inherent in precise thermal delivery systems. Implementing advanced equipment that guarantees uniform heating while protecting healthy tissue necessitates substantial capital investment and specialized personnel training, which limits accessibility in many healthcare institutions. Furthermore, inconsistent reimbursement policies across various regions frequently deter providers from adopting this technology, thereby restricting its reach and integration into standard care despite its demonstrated clinical efficacy.

Market Driver

The escalating global incidence of oncological disorders serves as the primary catalyst for market growth, as the rising disease burden mandates the widespread implementation of adjunctive therapies. As cancer rates increase, healthcare systems are driven to incorporate methods such as hyperthermia to boost the efficacy of standard treatment protocols. In February 2024, the World Health Organization reported in its 'Global Cancer Burden' release that approximately 20 million new cancer cases were documented globally in 2022. This growing patient volume is particularly significant for deep-seated and refractory malignancies, creating a large addressable market for specialized thermal treatments; notably, the same report identified lung cancer as the most common form worldwide with 2.5 million new cases, representing a key target for deep regional hyperthermia applications meant to potentiate radiation effects.

Simultaneously, the expansion of public and private funding for cancer care infrastructure is greatly accelerating market adoption, fueled by investments in specialized treatment centers. Hospitals and research institutes are actively upgrading their therapeutic facilities to include advanced thermal delivery systems, thereby improving patient access to multimodal care. This trend is demonstrated by the rapid growth of dedicated facilities; according to a 2024 operational update from Pyrexar Medical, a leading oncology hospital in China is expanding its capacity to operate 20 hyperthermia devices by the end of the year. Such infrastructural developments reflect a shifting medical consensus toward integrating thermal therapy into mainstream oncology workflows to maximize clinical success.

Market Challenge

The significant cost and technical intricacy associated with precise thermal delivery systems present a major obstacle to the expansion of the hyperthermia cancer treatment market. Adopting these advanced multimodal therapies requires healthcare facilities to invest heavily in sophisticated machinery capable of ensuring uniform heating while safeguarding healthy tissues. In addition to the initial capital expenditure, the necessity for specialized training to operate these complex systems creates an operational barrier, effectively limiting adoption to well-funded research centers and restricting widespread clinical accessibility.

Moreover, variability in reimbursement coverage severely compromises the financial feasibility of integrating this technology into standard practice. When providers are unable to secure consistent payment for capital-intensive procedures, the economic risks often outweigh the clinical benefits. This difficult fiscal landscape is evidenced by recent policy adjustments; according to the American Society for Radiation Oncology in 2024, the finalized Medicare Physician Fee Schedule imposed a reimbursement reduction of approximately 2% for radiation oncology services, continuing a decade-long trend of declining payments for equipment-heavy treatments. Such diminishing financial support directly hampers the ability of medical providers to acquire and maintain necessary hyperthermia systems, thereby stalling market growth.

Market Trends

The adoption of MRI-Guided Real-Time Temperature Monitoring Systems is revolutionizing the market by fulfilling the critical requirement for precise thermal dosimetry. This trend marks a technological advancement from static heating to dynamic, image-guided interventions that enable clinicians to visualize temperature distribution in real-time and adjust energy delivery instantly. The industry's focus on validating these precision platforms is attracting significant investment; for example, Sensius B.V. announced in a June 2025 press release that it secured €15 million in funding to accelerate the international clinical deployment of its precision thermotherapy platform, signaling growing commercial confidence in image-guided solutions for head and neck malignancies.

At the same time, the market is undergoing a decisive shift toward Non-Invasive Deep Tissue Microwave and Ultrasound Modalities, which remove the risks associated with interstitial catheter placement. This transition is gaining momentum as high-intensity focused ultrasound (HIFU) technologies mature, providing non-incisional options that effectively sensitize deep-seated tumors to concurrent therapies without requiring hospitalization. The expanding clinical presence of these non-invasive devices is reflected in a surge in global utilization; according to the Focused Ultrasound Foundation's '2024 State of the Field Report' released in July 2024, the sector saw a 44% increase in the number of patient treatments worldwide compared to the prior year, highlighting the rapid mainstream acceptance of non-invasive thermal techniques.

Key Market Players

• Pyrexar Medical
• MagForce AG
• Hydrosun Medizintechnik GmbH
• Andromedic Srl
• YAMAMOTO VINITA CO., LTD
• OncoTherm Kft.
• Nanoprobes, Inc.
• Chongqing Haifu Medical Technology Co., Ltd.
• Novavida Integrative Medical Center
• InnoMedicus Ltd.

Report Scope

In this report, the Global Hyperthermia Cancer Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hyperthermia Cancer Treatment Market, By Device Type

• Microwave Hyperthermia Device
• Ultrasound Hyperthermia Device
• Infrared Hyperthermia Device
• Short-wave Hyperthermia Device

Hyperthermia Cancer Treatment Market, By Application

• Prostate Cancer
• Breast Cancer
• Cervical Cancer
• Skin Cancer
• Other Cancers

Hyperthermia Cancer Treatment Market, By End User

• Hospitals & Clinics
• Specialty Centers
• Others

Hyperthermia Cancer Treatment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hyperthermia Cancer Treatment Market.

Available Customizations:

Global Hyperthermia Cancer Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hyperthermia Cancer Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, Short-wave Hyperthermia Device)
  • 5.2.2. By Application (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, Other Cancers)
  • 5.2.3. By End User (Hospitals & Clinics, Specialty Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Hyperthermia Cancer Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hyperthermia Cancer Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Hyperthermia Cancer Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Hyperthermia Cancer Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Hyperthermia Cancer Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hyperthermia Cancer Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Hyperthermia Cancer Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Hyperthermia Cancer Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Hyperthermia Cancer Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Hyperthermia Cancer Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Hyperthermia Cancer Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hyperthermia Cancer Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Hyperthermia Cancer Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Hyperthermia Cancer Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Hyperthermia Cancer Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Hyperthermia Cancer Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Hyperthermia Cancer Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hyperthermia Cancer Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Hyperthermia Cancer Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Hyperthermia Cancer Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Hyperthermia Cancer Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hyperthermia Cancer Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Hyperthermia Cancer Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Hyperthermia Cancer Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hyperthermia Cancer Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Pyrexar Medical
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. MagForce AG
• 15.3. Hydrosun Medizintechnik GmbH
• 15.4. Andromedic Srl
• 15.5. YAMAMOTO VINITA CO., LTD
• 15.6. OncoTherm Kft.
• 15.7. Nanoprobes, Inc.
• 15.8. Chongqing Haifu Medical Technology Co., Ltd.
• 15.9. Novavida Integrative Medical Center
• 15.10. InnoMedicus Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer